TASIn ForceAct
End-of-Life Choices (Voluntary Assisted Dying) Act 2021
75Duties of AHP when VAD substance supplied to AHP by PMP
Start here
Get a plain-English read of 75
Turn the raw legal text into a practical explanation grounded in End-of-Life Choices (Voluntary Assisted Dying) Act 2021.
### 75 Duties of AHP when VAD substance supplied to AHP by PMP
> > (1) If a VAD substance is supplied to an AHP under [section 74(1)](#GS74@Gs1@EN) , the AHP must ensure that –
> >
> > > > (a) the substance is contained in a locked receptacle that is not readily accessible by any other person; and
> > >
> > > > (b) the substance is kept at the AHP’s usual place of employment as a registered health practitioner.
>
> > (2) [Subsection (1)](#GS75@Gs1@EN) does not apply in relation to a person’s AHP, in respect of a VAD substance, if –
> >
> > > > (a) the substance is in the immediate physical possession of the AHP and is being transported to another place –
> > > >
> > > > > > (i) for administration to the person; or
> > > > >
> > > > > > (ii) for provision of the substance to the person for the person to self-administer; or
> > >
> > > > (b) the substance is in the immediate physical possession of the AHP and is not readily accessible by any other person; or
> > >
> > > > (c) the substance is being administered to the person by the AHP; or
> > >
> > > > (d) the substance has been given to the person to self-administer; or
> > >
> > > > (e) the AHP has, under [section 76(3)](#GS76@Gs3@EN) , returned the substance to the pharmacist who supplied it to the PMP.